240 research outputs found
Dynamics of cancer care results in Ekaterinburgβs population over the past 10 years
Due the unreliable data presentation about cancer death rate in Ekaterinburg's population the results of cancer care were evaluated by using dynamics of coefficient both accumulation and mortality in registered patients. To demonstrate outcomes in registered patients with the most common cancer an index of annual contingent's preservation was calculated.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ Π½Π°ΡΠ΅Π»Π΅Π½ΠΈΡ Π³. ΠΠΊΠ°ΡΠ΅ΡΠΈΠ½Π±ΡΡΠ³Π° Π² ΡΠ²ΡΠ·ΠΈ Ρ Π½Π΅Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎΡΡΡΡ ΡΠ²Π΅Π΄Π΅Π½ΠΈΠΉ ΠΎΠ± ΡΠΌΠΈΡΠ°ΡΡΠΈΡ
ΠΎΡ ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΡΡ
Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ ΠΎΡΠ΅Π½Π΅Π½Ρ ΠΏΠΎ Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠ΅ ΠΊΠΎΡΡΡΠΈΡΠΈΠ΅Π½ΡΠ° Π½Π°ΠΊΠΎΠΏΠ»Π΅Π½ΠΈΡ ΠΈ Π»Π΅ΡΠ°Π»ΡΠ½ΠΎΡΡΠΈ ΡΠΎΡΡΠΎΡΡΠΈΡ
Π½Π° ΡΡΡΡΠ΅. ΠΠ»Ρ Π½Π°Π³Π»ΡΠ΄Π½ΠΎΡΡΠΈ ΡΡΠ΄ΡΠ±Ρ ΡΠΎΡΡΠΎΡΡΠΈΡ
Π½Π° ΡΡΡΡΠ΅ ΠΎΠ½ΠΊΠΎΠ±ΠΎΠ»ΡΠ½ΡΡ
Π²ΡΡΠΈΡΠ»Π΅Π½ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Ρ Π΅ΠΆΠ΅Π³ΠΎΠ΄Π½ΠΎΠ³ΠΎ ΡΠΎΡ
ΡΠ°Π½Π΅Π½ΠΈΡ ΠΊΠΎΠ½ΡΠΈΠ½Π³Π΅Π½ΡΠΎΠ² Ρ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π²Π°ΠΆΠ½ΡΠΌΠΈ Π»ΠΎΠΊΠ°Π»ΠΈΠ·Π°ΡΠΈΡΠΌΠΈ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
ΠΎΠΏΡΡ
ΠΎΠ»Π΅ΠΉ
Objectivity estimations of a condition of the oncological help
Conditions of the oncological help Now in use for an estimation in various territories parameters of parities early (I, II) and started (IV) stages, percent of the patients revealed on ΠΏΡΠΎΡΠΎΡΠΌΠΎΡΡΠ°Ρ
, percent among living 5 years consisting on the account more are not objective as it is frequent ΠΊΠΎΡΡΠΈΠ³ΠΈΡΡΡΡΡΡ. The author as really objective, are offered - relative death rate (percent died from number ill) and relative survival rate (number the return from relative death rate: 100 - percent died) for 5-years time intervals. Their comparison with ΠΏΠ΅ΡΠ²ΠΎΠ³ΠΎΠ΄ΠΈΡΠ½ΠΎΠΉ Π»Π΅ΡΠ°Π»ΡΠ½ΠΎΡΡΡΡ allows to receive representation about the contribution to dynamics of results of the oncological help of perfection of medical actions and early diagnostics.ΠΡΠΏΠΎΠ»ΡΠ·ΡΠ΅ΠΌΡΠ΅ Π² Π½Π°ΡΡΠΎΡΡΠ΅Π΅ Π²ΡΠ΅ΠΌΡ Π΄Π»Ρ ΠΎΡΠ΅Π½ΠΊΠΈ ΡΠΎΡΡΠΎΡΠ½ΠΈΡ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ Π½Π° ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ
ΡΠ΅ΡΡΠΈΡΠΎΡΠΈΡΡ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ ΡΠΎΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΠΉ ΡΠ°Π½Π½ΠΈΡ
(1,11) ΠΈ Π·Π°ΠΏΡΡΠ΅Π½Π½ΠΎΠΉ (IV) ΡΡΠ°Π΄ΠΈΠΉ, ΠΏΡΠΎΡΠ΅Π½Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
, Π²ΡΡΠ²Π»Π΅Π½Π½ΡΡ
Π½Π° ΠΏΡΠΎΡΠΎΡΠΌΠΎΡΡΠ°Ρ
, ΠΏΡΠΎΡΠ΅Π½Ρ ΡΡΠ΅Π΄ΠΈ ΡΠΎΡΡΠΎΡΡΠΈΡ
Π½Π° ΡΡΡΡΠ΅ ΠΆΠΈΠ²ΡΡΠΈΡ
Π±ΠΎΠ»Π΅Π΅ 5 Π»Π΅Ρ Π½Π΅ ΡΠ²Π»ΡΡΡΡΡ ΠΎΠ±ΡΠ΅ΠΊΡΠΈΠ²Π½ΡΠΌΠΈ, ΡΠ°ΠΊ ΠΊΠ°ΠΊ ΡΠ°ΡΡΠΎ ΠΊΠΎΡΡΠΈΠ³ΠΈΡΡΡΡΡΡ. ΠΠ²ΡΠΎΡΠΎΠΌ, ΠΊΠ°ΠΊ Π΄Π΅ΠΉΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎ ΠΎΠ±ΡΠ΅ΠΊΡΠΈΠ²Π½ΡΠ΅, ΠΏΡΠ΅Π΄Π»ΠΎΠΆΠ΅Π½Ρ - ΠΎΡΠ½ΠΎΡΠΈΡΠ΅Π»ΡΠ½Π°Ρ ΡΠΌΠ΅ΡΡΠ½ΠΎΡΡΡ (ΠΏΡΠΎΡΠ΅Π½Ρ ΡΠΌΠ΅ΡΡΠΈΡ
ΠΎΡ ΡΠΈΡΠ»Π° Π·Π°Π±ΠΎΠ»Π΅Π²ΡΠΈΡ
) ΠΈ ΠΎΡΠ½ΠΎΡΠΈΡΠ΅Π»ΡΠ½Π°Ρ Π²ΡΠΆΠΈΠ²Π°Π΅ΠΌΠΎΡΡΡ (ΡΠΈΡΠ»ΠΎ ΠΎΠ±ΡΠ°ΡΠ½ΠΎΠ΅ ΠΎΡ ΠΎΡΠ½ΠΎΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠΌΠ΅ΡΡΠ½ΠΎΡΡΠΈ: 100% - ΠΏΡΠΎΡΠ΅Π½Ρ ΡΠΌΠ΅ΡΡΠΈΡ
) Π·Π° 5-Π»Π΅ΡΠ½ΠΈΠ΅ ΠΏΡΠΎΠΌΠ΅ΠΆΡΡΠΊΠΈ Π²ΡΠ΅ΠΌΠ΅Π½ΠΈ. ΠΡ
ΡΠΎΠΏΠΎΡΡΠ°Π²Π»Π΅Π½ΠΈΠ΅ Ρ ΠΏΠ΅ΡΠ²ΠΎΠ³ΠΎΠ΄ΠΈΡΠ½ΠΎΠΉ Π»Π΅ΡΠ°Π»ΡΠ½ΠΎΡΡΡΡ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ ΠΏΠΎΠ»ΡΡΠΈΡΡ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ΠΈΠ΅ ΠΎ Π²ΠΊΠ»Π°Π΄Π΅ Π² Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΡ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ ΡΠΎΠ²Π΅ΡΡΠ΅Π½ΡΡΠ²ΠΎΠ²Π°Π½ΠΈΡ Π»Π΅ΡΠ΅Π±Π½ΡΡ
ΠΌΠ΅ΡΠΎΠΏΡΠΈΡΡΠΈΠΉ ΠΈ ΡΠ°Π½Π½Π΅ΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ
Therapy of pathology secretory disease of the breast
Pathogenesis of serous discharge from the nipples of the breast is complex and includes the following components: hormonal imbalanceΒ as a backdrop, stimulating increased secretion in the ducts of serous content, resorption of the liquid component of a secret, resultingΒ in local pathological effects of protein resorption, hormone content, autoimmune reactions ductless with subsequent development of proliferativeΒ processes in them.Β Under adverse conditions, infection occurs from an external or internal source of microorganisms. The presence of fluid in the ducts, mammaryΒ system ductal communication with the external environment, is an βopen gateβ for content ductal infection of the mammary glands.Β This creates the prerequisites for the development of proliferative processes in the first phase of the inflammatory origin.Β Application of 194 women with serous secretions from the nipples of the breast combined combinations of enzymes, glucocorticoids, progestogens,Β gonadoliberins and other agonists, suppress the proliferation of drugs that helped to put an end to abnormal secretion and preventΒ changes in the walls of the ducts and periductal breast tissue at different stages of disease
- β¦